Outsourcing facilities and their place in the U.S. drug supply chain

The purpose of this commentary is to describe the ideal role of 503B outsourcing facilities in the U.S. drug supply chain. We also address the challenges that 503B outsourcing facilities are facing that limit their utilization and offer possible solutions. Section 503B outsourcing facilities are eme...

Descripción completa

Detalles Bibliográficos
Autores principales: Gianturco, Stephanie L., Yoon, SeJeong, Yuen, Melissa V., Mattingly, Ashlee N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Pharmacists Association®. Published by Elsevier Inc. 2021
Materias:
Science and Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7453203/
https://www.ncbi.nlm.nih.gov/pubmed/32863181
http://dx.doi.org/10.1016/j.japh.2020.07.021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7453203/
https://www.ncbi.nlm.nih.gov/pubmed/32863181
http://dx.doi.org/10.1016/j.japh.2020.07.021

Ejemplares similares